However, inflammatory cytokines TNF-α, IL-1β, and IL-6 are important in atherosclerosis pathogenesis, as recently shown by the CANTOS trial, which found that specifically targeting inflammation (IL-1β inhibition) improves clinical outcomes in patients with a previous myocardial infarction.16 Here, IL6 is linked to myocardial infarction.